Aomura, D.; Harada, M.; Yamada, Y.; Nakajima, T.; Hashimoto, K.; Tanaka, N.; Kamijo, Y.
Pemafibrate Protects against Fatty Acid-Induced Nephropathy by Maintaining Renal Fatty Acid Metabolism. Metabolites 2021, 11, 372.
https://doi.org/10.3390/metabo11060372
AMA Style
Aomura D, Harada M, Yamada Y, Nakajima T, Hashimoto K, Tanaka N, Kamijo Y.
Pemafibrate Protects against Fatty Acid-Induced Nephropathy by Maintaining Renal Fatty Acid Metabolism. Metabolites. 2021; 11(6):372.
https://doi.org/10.3390/metabo11060372
Chicago/Turabian Style
Aomura, Daiki, Makoto Harada, Yosuke Yamada, Takero Nakajima, Koji Hashimoto, Naoki Tanaka, and Yuji Kamijo.
2021. "Pemafibrate Protects against Fatty Acid-Induced Nephropathy by Maintaining Renal Fatty Acid Metabolism" Metabolites 11, no. 6: 372.
https://doi.org/10.3390/metabo11060372
APA Style
Aomura, D., Harada, M., Yamada, Y., Nakajima, T., Hashimoto, K., Tanaka, N., & Kamijo, Y.
(2021). Pemafibrate Protects against Fatty Acid-Induced Nephropathy by Maintaining Renal Fatty Acid Metabolism. Metabolites, 11(6), 372.
https://doi.org/10.3390/metabo11060372